首页|阿仑磷酸钠辅助PVP治疗对老年骨质疏松性压缩性骨折BALP、PTH及N-MID-OT水平的影响

阿仑磷酸钠辅助PVP治疗对老年骨质疏松性压缩性骨折BALP、PTH及N-MID-OT水平的影响

扫码查看
目的 分析阿仑磷酸钠辅助经皮椎体成形术(PVP)治疗对老年骨质疏松性压缩性骨折骨碱性磷酸酶(BALP)、甲状旁腺激素(PTH)及N端中段骨钙素(N-MID-OT)水平的影响.方法 选取2019年1月至2022年2月唐山市丰润区人民医院收治的老年骨质疏松性压缩性骨折患者107例,按照治疗方式不同分为观察组和对照组,对照组采取PVP治疗(n=52),观察组采取阿仑磷酸钠辅助PVP治疗(n=55).对比两组Oswestry功能障碍指数问卷表(ODI)、视觉模拟量表(VAS)、骨代谢指标(BALP、PTH、N-MID-OT水平)、不良反应及再骨折发生率.结果 两组术后2个月、6个月、12个月ODI评分均下降,且观察组术后各时间段ODI评分均低于对照组,差异有统计学意义(P<0.05).两组术后2个月、6 个月、12个月VAS评分均下降,且观察组术后各时间段VAS评分均低于对照组,差异有统计学意义(P<0.05).两组术后BALP、PTH及N-MID-OT水平均下降,且观察组术后BALP、PTH及N-MID-OT水平均低于对照组,差异有统计学意义(P<0.05).两组不良反应总发生率对比,差异无统计学意义(P>0.05),但观察组再骨折发生率(7.28%)明显低于对照组(25.00%),差异有统计学意义(P<0.05).结论 阿仑磷酸钠辅助PVP治疗可有效改善老年骨质疏松性压缩性骨折患者椎体功能,减轻其疼痛程度,改善患者体内BALP、PTH及N-MID-OT水平,促进其术后恢复.
Effects of alendronate sodium adjuvant PVP therapy on BALP,PTH and N-MID-OT lev-els in elderly patients with osteoporotic compression fractures
Objective To analyze the effects of alendronate-assisted percutaneous vertebroplasty(PVP)in the treatment of osteoporotic compression fractures in elderly patients on bone alkaline phasphatase(BALP),parathyroid hormone(PTH)and N-end middle Osteocalcin(N-MID-OT)levels.Methods 107 el-derly patients with osteoporotic compression fracture treated in Fenggrun District People's Hospital of Tang-shan City from January 2019 to February 2022 were selected and divided into an observation group and a con-trol group according to different treatment methods,the control group was treated with PVP(n=52),the ob-servation group took alendronate sodium as auxiliary PVP treatment(n=55).The Oswestry Disability Index questionnaire(ODI),visual analogue scale(VAS),bone metabolism indicators(BALP,PTH,N-MID-OT levels),adverse reactions and the incidence of refracture between the two groups were compared.Results The ODI scores of both groups decreased at 2 months,6 months,and 12 months after operation,and the ODI scores of the observation group were lower than those of the control group at all time periods after surgery,the difference was statistically significant(P<0.05).The VAS scores of both groups decreased at 2 months,6 months,and 12 months after surgery,and the VAS scores of the observation group were lower than those of the control group at all time periods after surgery,the difference was statistically significant(P<0.05).The levels of BALP,PTH and N-MID-OT in both groups decreased after operation,and the levels of BALP,PTH and N-MID-OT in the observation group were lower than those in the control group,the difference was statistically signifi-cant(P<0.05).Comparing the total incidence of adverse reactions between the two groups,the difference was not statistically significant,the difference was statistically significant(P>0.05),but the incidence of re-fracture in the observation group(7.28%)was significantly lower than that in the control group(25.00%),the difference was statistically significant(P<0.05).Conclusion Alendronate sodium adjuvant PVP therapy can effectively improve the vertebral function of elderly patients with osteoporotic compression fractures,reduce their pain,im-prove the levels of BALP,PTH and N-MID-OT in patients,and promote their postoperative recovery.

AlendronatePercutaneous vertebroplastyOsteoporotic compression fractureBone alkaline phosphataseParathyroid hormoneN-MID-OT

田晓芳、田国华、郑艳杰、刘春香

展开 >

唐山市丰润区人民医院骨三科,河北,唐山 064000

阿仑磷酸钠 经皮椎体成形术 骨质疏松性压缩性骨折 骨碱性磷酸酶 甲状旁腺激素 N-MID-OT

河北省医学科学研究项目

20220347

2024

分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
年,卷(期):2024.16(1)
  • 13